Ovarian epithelial cancer recurrent
Information
- Disease name
- Ovarian epithelial cancer recurrent
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01376752 | Active, not recruiting | Phase 3 | Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in Relapse Ovarian Cancer Treatment | April 26, 2011 | May 14, 2025 |
| NCT01588964 | Completed | Phase 2 | IPHC in Patients With Platinum-sensitive Recurrent Ovarian Cancer | March 2005 | December 2011 |
| NCT02735928 | Completed | N/A | Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Applied to Platinum-Resistant Recurrence of Ovarian Tumor | January 2016 | June 16, 2022 |
| NCT02260544 | Completed | Phase 1 | Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection | July 2014 | August 2015 |
| NCT02394015 | Completed | Retrospective Study to Analyze the Efficacy and Safety of Trabectedin and Pegylated Liposomal Doxorubicin (PLD ) in the Treatment of Patients With Platinum-sensitive Recurrent Ovarian Cancer (ROC), According to SmPC | May 6, 2013 | December 2017 | |
| NCT01735071 | Completed | Phase 2 | Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian Cancer | July 2013 | March 18, 2018 |
| NCT01899599 | Completed | Phase 2 | PankoMab-GEX™ Versus Placebo as Maintenance Therapy in Advanced Ovarian Cancer | September 2013 | July 28, 2017 |
| NCT02014337 | Completed | Phase 1 | Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors | January 2014 | December 2017 |
| NCT02026921 | Completed | Phase 2 | A Phase II Study of Docetaxel and Carboplatin in Late Relapse of Ovarian Cancer | June 2004 | December 2008 |
| NCT01715168 | Unknown status | Phase 1 | A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer | October 2012 | December 2015 |
| NCT01611766 | Unknown status | Phase 3 | Surgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)? | July 19, 2012 | December 2022 |